Document Detail


Genotoxic and cytotoxic activity of host defense peptides against human soft tissue sarcoma in an in vitro model.
MedLine Citation:
PMID:  21851146     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Soft tissue sarcomas (STSs) are a heterogeneous group of rare, mesenchymal tumors. Treatment with common chemotherapeutic drugs is consistently associated with low response rates and high rates of adverse toxic effects. Host defense peptides (HDPs) are used as part of innate immunity, and many of them act by directly lysing the target cell membrane. Studies have demonstrated high selectivity of HDP analogs against malignant cells because of a relative abundance of negative charges in malignant cell membranes, compared to normal cells. Our aim was to assess the toxic efficacy of [D]-K(6)L(9), [D]-K(3)H(3)L(9), and Protegrin-1 against the fibrosarcoma cell line, HT1080, and primary human fibroblasts to analyze the potential of these peptides as therapeutic options against STSs. Cell proliferation of the fibrosarcoma cell line, HT1080, and human fibroblasts was determined in vitro after treatment with [D]-K(6)L(9), [D]-K(3)H(3)L(9), and Protegrin-1. Genotoxicity was examined on the basis of the mild alkali version of single-cell gel electrophoresis (comet assay). Doxorubicin, a commonly used STS chemotherapeutic agent, served as the control. The native HDP, Protegrin-1, could show a cytotoxic tendency against malignant cells, but no selectivity in genotoxic trials. The synthetic peptide, [D]-K(6)L(9), could not show any selective oncolytic activity against sarcoma cells. [D]-K(3)H(3)L(9) has shown a tendency for toxic selectivity against malignant cells. There is a potential of developing suitable oncolytic candidates with selectivity against malignant cells. [D]-K(3)H(3)L(9) showed the first promising results, but there has to be further investigation to improve the therapeutic properties of HDPs.
Authors:
Lars Steinstraesser; Jennifer Hauk; Sammy Al-Benna; Stefan Langer; Andrej Ring; Marco Kesting; Holger Sudhoff; Mustafa Becerikli; Heiko Käefferlein; Frank Jacobsen
Related Documents :
21918676 - High-throughput size-based rare cell enrichment using microscale vortices.
21668266 - Langevin dynamics deciphers the motility pattern of swimming parasites.
22261246 - Growth of zno nanowires on fibers for one-dimensional flexible quantum dot-sensitized s...
21634026 - Inhibition of myosin ii triggers morphological transition and increased nuclear motility.
21918676 - High-throughput size-based rare cell enrichment using microscale vortices.
15491516 - Apoptosis of pancreatic acinar cells in acute pancreatitis: is it good or bad?
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-18
Journal Detail:
Title:  Drug and chemical toxicology     Volume:  -     ISSN:  1525-6014     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-8-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7801723     Medline TA:  Drug Chem Toxicol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Laboratory for Molecular Oncology and Wound Healing, Department of Plastic Surgery, BG University Hospital Bergmannsheil, Ruhr-University Bochum , Bochum , Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The FLU-FIT program: an effective colorectal cancer screening program for high volume flu shot clini...
Next Document:  Evidence that process simulations reduce anxiety in patients receiving dental treatment: randomized ...